ZDHHC9 and glioblastoma: Our findings demonstrate that knockout of palmitoyltransferase DHHC9 or disruption of DHHC9-mediated GLUT1 S-palmitoylation by site-specific point mutation inhibited growth and colony formation of GBM cells in vitro and GBM tumorigenesis in vivo.